Mutations associated with both cerebellar- and retinal-hemangioblastoma localize in regions not affecting the pVHL interaction with transcription factors (TP53, ELAVL1) and regulators (ID2, E2F1, ELOC). This evidence concerns the gene ELAVL1 and retinal hemangioblastoma.